Authors are on the European Eye Epidemiology (E3) Consortium. Presented at: Association for Research in Vision and Ophthalmology Annual Meeting, May 2014, Orlando, Florida (United States). Manuscript no. 2017-1933. Supplemental material available at www.aaojournal.org.International audienceTOPIC:To estimate the prevalence of nonrefractive visual impairment and blindness in European persons 55 years of age and older.CLINICAL RELEVANCE:Few visual impairment and blindness prevalence estimates are available for the European population. In addition, many of the data collected in European population-based studies currently are unpublished and have not been included in previous estimates.METHODS:Fourteen European population-based studies participa...
PURPOSE: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
Background: To assess prevalence and causes of blindness and vision impairment in high-income region...
Manuscript no. 2016-1147 Supplemental material is available at www.aaojournal.org/International audi...
Authors are on the European Eye Epidemiology (E3) Consortium. Presented at: Association for Research...
TOPIC: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
TOPIC To estimate the prevalence of nonrefractive visual impairment and blindness in European per...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
PURPOSE: To determine the prevalence of visual impairment (VI) in populations 65 year or older from ...
Purpose: To determine the prevalence of visual impairment (VI) in populations 65 year or older from ...
Purpose: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
To determine the prevalence of visual impairment (VI) in populations 65 year or older from six Europ...
Open access articleInternational audienceBackground Within a surveillance of the prevalence and caus...
textabstractObjective: To estimate the prevalence of age-related maculopathy in an older population ...
Purpose: Vision impairment is a leading and largely preventable cause of disability worldwide. Howev...
PURPOSE: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
Background: To assess prevalence and causes of blindness and vision impairment in high-income region...
Manuscript no. 2016-1147 Supplemental material is available at www.aaojournal.org/International audi...
Authors are on the European Eye Epidemiology (E3) Consortium. Presented at: Association for Research...
TOPIC: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
TOPIC To estimate the prevalence of nonrefractive visual impairment and blindness in European per...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
Topic: To estimate the prevalence of nonrefractive visual impairment and blindness in European perso...
PURPOSE: To determine the prevalence of visual impairment (VI) in populations 65 year or older from ...
Purpose: To determine the prevalence of visual impairment (VI) in populations 65 year or older from ...
Purpose: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
To determine the prevalence of visual impairment (VI) in populations 65 year or older from six Europ...
Open access articleInternational audienceBackground Within a surveillance of the prevalence and caus...
textabstractObjective: To estimate the prevalence of age-related maculopathy in an older population ...
Purpose: Vision impairment is a leading and largely preventable cause of disability worldwide. Howev...
PURPOSE: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...
Background: To assess prevalence and causes of blindness and vision impairment in high-income region...
Manuscript no. 2016-1147 Supplemental material is available at www.aaojournal.org/International audi...